Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Plain Language in Plain Sight: Why Making It Easier for Patients to Access Content They Understand Pays Off
With so many different types of Plain Language Summaries, and the interchangeable terms used for...
World Patient Safety Day 2022 – Medication Without Harm
Medication use around the world has increased in the last few years; a 2019 CDC...
HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
Bite-Sized Content Helps Avoid User Fatigue – How Can Pharma Use It?
Today's readers tend to avoid long pharma content and medical jargon. If you want to...
Why the Healthcare Industry MUST Care About the Caregiver
Caregivers are vital in the treatment of a patient, whether at home or in a...
What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...